ArticleInflammatory intestinal diseases

Real-World Adherence and Relapse Risk in Mesalamine Treatment for Ulcerative Colitis: Insights from a Large Japanese Medical Claims Database.

Takafumi Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.